Home

ROBERT J DELUCCIA

CIK 1127423 · Executive Chairman · last filed 2026-04-22

ROBERT J DELUCCIA is an Executive Chairman who has filed 16 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for ACXP, was dated Apr 22, 2026. Across all open-market trades the lifetime net is +$174.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $74.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$74.5K

Companies

3

Total Filings

16

Lifetime Open-Market Net

$174.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACXP Director 50,702 $1.47 $74.5K $149.7K 9 2026-04-22
PLx Pharma Inc. (PLXP) Delisted Executive Chairman — $0.09 — $0 1 2017-04-20
PLx Pharma Inc. (DPRX) Delisted Executive Chairman 228,914 — — $25.0K 3 2016-01-21

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-22 ACXP Grant (A) — $0 EDGAR
2025-02-06 ACXP Grant (A) — $0 EDGAR
2025-01-08 ACXP Buy (P) +49,261 $50.0K EDGAR
2024-04-03 ACXP Grant (A) — $0 EDGAR
2024-01-04 ACXP Mixed −90,263 $70.1K EDGAR
2023-02-24 ACXP Grant (A) — $0 EDGAR
2022-07-29 ACXP Buy (P) +19,737 $75.0K EDGAR
2021-11-22 ACXP Buy (P) +5,034 $24.7K EDGAR
2021-07-06 ACXP Grant (A) — $0 EDGAR
2017-04-20 PLx Pharma Inc. (PLXP) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.